PMID- 23973363 OWN - NLM STAT- MEDLINE DCOM- 20140516 LR - 20211021 IS - 1872-7123 (Electronic) IS - 0165-1781 (Print) IS - 0165-1781 (Linking) VI - 214 IP - 2 DP - 2013 Nov 30 TI - Methylphenidate remediates error-preceding activation of the default mode brain regions in cocaine-addicted individuals. PG - 116-21 LID - S0925-4927(13)00181-9 [pii] LID - 10.1016/j.pscychresns.2013.06.009 [doi] AB - Many previous studies suggest the potential of psychostimulants in improving cognitive functioning. Our earlier pharmacological brain imaging study showed that intravenous methylphenidate (MPH) improves inhibitory control by altering cortico-striato-thalamic activations in cocaine-dependent (CD) individuals. Here we provide additional evidence for the effects of MPH in restoring cerebral activations during cognitive performance. Ten CD individuals performed a stop signal task (SST) during functional magnetic resonance imaging (fMRI) in two sessions, in which either MPH (0.5mg/kg body weight) or saline was administered intravenously. In the SST, a frequent go signal instructs participants to make a speeded response and a less frequent stop signal instructs them to withhold the response. Our previous work described increased activation of the precuneus/posterior cingulate cortex and ventromedial prefrontal cortex-regions of the default mode network (DMN)-before participants committed a stop error in healthy control but not CD individuals (Bednarski et al., 2011). The current results showed that, compared to saline, MPH restored error-preceding activations of DMN regions in CD individuals. The extent of the changes in precuneus activity was correlated with MPH-elicited increase in systolic blood pressure. These findings suggest that the influence of MPH on cerebral activations may extend beyond cognitive control and provide additional evidence warranting future studies to investigate the neural mechanisms and physiological markers of the efficacy of agonist therapy in cocaine dependence. CI - (c) 2013 Elsevier Ireland Ltd. All rights reserved. FAU - Matuskey, David AU - Matuskey D AD - Department of Psychiatry, Yale University, New Haven, CT 06519, USA. FAU - Luo, Xi AU - Luo X FAU - Zhang, Sheng AU - Zhang S FAU - Morgan, Peter T AU - Morgan PT FAU - Abdelghany, Osama AU - Abdelghany O FAU - Malison, Robert T AU - Malison RT FAU - Li, Chiang-shan R AU - Li CS LA - eng GR - K02DA026990/DA/NIDA NIH HHS/United States GR - R21 DA026998/DA/NIDA NIH HHS/United States GR - T32MH019961/MH/NIMH NIH HHS/United States GR - T32 MH019961/MH/NIMH NIH HHS/United States GR - R03DA022395/DA/NIDA NIH HHS/United States GR - K02 DA026990/DA/NIDA NIH HHS/United States GR - K24 DA017899/DA/NIDA NIH HHS/United States GR - R03 DA022395/DA/NIDA NIH HHS/United States GR - UL1 RR024139/RR/NCRR NIH HHS/United States GR - K24-DA017899/DA/NIDA NIH HHS/United States GR - R01 DA023248/DA/NIDA NIH HHS/United States GR - UL1RR024139/RR/NCRR NIH HHS/United States PT - Journal Article PT - Research Support, N.I.H., Extramural PT - Research Support, Non-U.S. Gov't DEP - 20130823 PL - Ireland TA - Psychiatry Res JT - Psychiatry research JID - 7911385 RN - 0 (Central Nervous System Stimulants) RN - 207ZZ9QZ49 (Methylphenidate) RN - S88TT14065 (Oxygen) SB - IM MH - Adult MH - Central Nervous System Stimulants/*therapeutic use MH - Cerebral Cortex/blood supply/*drug effects MH - Cocaine-Related Disorders/*complications/pathology MH - Cognition Disorders/*drug therapy/*etiology MH - Female MH - Humans MH - Image Processing, Computer-Assisted MH - Inhibition, Psychological MH - Magnetic Resonance Imaging MH - Male MH - Methylphenidate/*therapeutic use MH - Middle Aged MH - Models, Neurological MH - Neural Pathways/drug effects/pathology MH - Neuropsychological Tests MH - Oxygen/blood MH - Photic Stimulation MH - Reaction Time/drug effects PMC - PMC3811038 MID - NIHMS520292 OTO - NOTNLM OT - Catecholamine OT - Cognitive control OT - Default mode network OT - Functional magnetic resonance imaging (fMRI) OT - Stimulants EDAT- 2013/08/27 06:00 MHDA- 2014/05/17 06:00 PMCR- 2014/11/30 CRDT- 2013/08/27 06:00 PHST- 2012/08/30 00:00 [received] PHST- 2013/06/05 00:00 [revised] PHST- 2013/06/14 00:00 [accepted] PHST- 2013/08/27 06:00 [entrez] PHST- 2013/08/27 06:00 [pubmed] PHST- 2014/05/17 06:00 [medline] PHST- 2014/11/30 00:00 [pmc-release] AID - S0925-4927(13)00181-9 [pii] AID - 10.1016/j.pscychresns.2013.06.009 [doi] PST - ppublish SO - Psychiatry Res. 2013 Nov 30;214(2):116-21. doi: 10.1016/j.pscychresns.2013.06.009. Epub 2013 Aug 23.